Skip to main content

Interleukin-10 promoter polymorphism IL10.G and familial early onset psoriasis

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Summary 

Background The anti-inflammatory cytokine interleukin (IL)-10 is considered to play a major role in the pathophysiology of psoriasis, which is characterized by an IL-10 deficiency. Systemic administration of IL-10 has been shown to be an effective therapy for psoriasis. The IL-10 promoter region contains a highly polymorphic microsatellite (IL10.G) and in a recent case–control study the IL10.G13 (144 bp) allele was found to be associated with familial early onset psoriasis (type 1 psoriasis) having a susceptible effect.

Objectives As it is essential in multifactorial diseases to replicate findings before definite conclusions can be drawn, we decided to perform a follow-up study and to follow a genetic approach analysing allele transmission in families with a positive family history of psoriasis.

Methods We studied 137 nuclear families (trio-design) comprising 456 individuals and genotyped the IL10.G marker. For comparison we also genotyped the microsatellite tn62 as a reference marker of the major psoriasis susceptibility locus on chromosome 6p21 (PSORS1). In the present study allele transmission was evaluated using the family-based association test (FBAT) and GENEHUNTER 2.0 based on the transmission/disequilibrium test.

Results The G13 allele (144 bp) had a frequency of 24%, was present in 88 families and clearly showed an even transmission (FBAT, P = 0·753). In contrast, allele 3 (IL10.G9) (136 bp) had a frequency of 39%, was present in 110 families and was transmitted in 43 trios and remained untransmitted in 67 trios (FBAT, P = 0·026), thus showing preferential nontransmission. For the HLA-linked tn62-marker we obtained a P-value of 0·000 27 for allele 4 in the same study group.

Conclusions In conclusion, we failed to confirm the susceptible effect of the G13 allele, but provide the first data for a protective effect of allele 3 (IL10.G9) for familial psoriasis. Our results suggest that the IL10.G polymorphism is not a major locus, but acts as a minor locus.

Keywords: complex diseases; cytokine; disease susceptibility; genetics; promoter polymorphism; psoriasis

Document Type: Research Article

DOI: http://dx.doi.org/10.1046/j.1365-2133.2003.05411.x

Affiliations: 1: Department of Dermatology, Medical School Charité, Humboldt University, Berlin and Research Business Area Dermatology, Schering AG, Berlin, Germany 2: Institute of Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany 3: Institute of Human Genetics, University of Erlangen-Nürnberg, Erlangen, Germany 4: Fachklinik Bad Bentheim, Bad Bentheim, Germany 5: Department of Public Health and Clinical Medicine, Section for Dermatology and Venereology, Umea University, Umea, Sweden 6: Department of Dermatology, University of Münster, Münster, Germany

Publication date: August 1, 2003

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more